Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 May;118(5):1211-23.
doi: 10.1097/ALN.0b013e31828ea597.

Anesthesia for in utero repair of myelomeningocele

Marla Ferschl  1 , Robert Ball, Hanmin Lee, Mark D Rollins
Affiliations
Case Reports

Anesthesia for in utero repair of myelomeningocele

Marla Ferschl et al. Anesthesiology. 2013 May.

Abstract

Recently published results suggest that prenatal repair of fetal myelomeningocele is a potentially preferable alternative when compared to postnatal repair. In this article, the pathology of myelomeningocele, unique physiologic considerations, perioperative anesthetic management, and ethical considerations of open fetal surgery for prenatal myelomeningocele repair are discussed. Open fetal surgeries have many unique anesthetic issues such as inducing profound uterine relaxation, vigilance for maternal or fetal blood loss, fetal monitoring, and possible fetal resuscitation. Postoperative management, including the requirement for postoperative tocolysis and maternal analgesia, are also reviewed. The success of intrauterine myelomeningocele repair relies on a well-coordinated multidisciplinary approach. Fetal surgery is an important topic for anesthesiologists to understand, as the number of fetal procedures is likely to increase as new fetal treatment centers are opened across the United States.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Term neonate with large lumbar myelomeningocele.
Figure 2
Figure 2. Operative Preparation for Open Myelomeningocele Repair
(A): Prior to uterine incision, the myelomeningocele is identified using ultrasound and positioned for repair. Arrows note sac border. This fetus has a L2 defect and is at a gestational age of 23 weeks. (B): The myelomeningocele sac is exposed for open surgical repair following uterine incision with use of lactomer uterine staples to prevent uterine wall hemorrhage. Profound uterine relaxation is achieved using high (>2 minimum alveolar concentration) inhalational anesthetic agent. Arrows labeled (MS) note myelomeningocele sac border and arrows labeled (LS) note lactomer staples. (C): An intramuscular muscle relaxant and opioid are injected into the fetus by the surgeon to ensure fetal immobility during the repair.
Figure 3
Figure 3. Intraoperative Myelomeningocele Repair
(A): Neural structures are exposed and separated from adjacent tissue. Labeled arrows note lactomer staples on the uterine wall (L), the skin edge (S), the myofascial flap (MF), and the neural placode (NP). (B): The dura is closed over the neural tube. (C): Once the dural closure is completed, surrounding tissue is mobilized for skin closure.
Figure 4
Figure 4. Prenatal fetal myelomeningocele defect primary closure
(A): Primary skin closure is performed when skin tissue can be approximated. (B): A scar over the surgical site remains at birth following a primary skin closure.
Figure 5
Figure 5. Prenatal fetal myelomeningocele defect closure using a patch
(A): An acellular dermal patch is used when the skin margins cannot be approximated to close the defect. (B): At birth, the patch is often not completely epithelilized, however, the majority of patients form granulation tissue over the patch in one-two weeks and further operative intervention is usually not necessary. (C): Occasionally the patch is completely covered by granulation tissue at birth.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shaer CM, Chescheir N, Schulkin J. Myelomeningocele: A review of the epidemiology, genetics, risk factors for conception, prenatal diagnosis, and prognosis for affected individuals. Obstet Gynecol Surv. 2007;62:471–9. - PubMed
    1. Boulet SL, Yang Q, Mai C, Kirby RS, Collins JS, Robbins JM, Meyer R, Canfield MA, Mulinare J. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol. 2008;82:527–32. - PubMed
    1. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. Spina bifida. Lancet. 2004;364:1885–95. - PubMed
    1. Thompson DN. Postnatal management and outcome for neural tube defects including spina bifida and encephalocoeles. Prenat Diagn. 2009;29:412–9. - PubMed
    1. Davis BE, Daley CM, Shurtleff DB, Duguay S, Seidel K, Loeser JD, Ellenbogan RG. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg. 2005;41:186–91. - PubMed

Publication types